HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georgia Atlanta Centers for Disease Control and Prevention Tuberculosis Trials Consortium Selected Research

Rifampin (Rifampicin)

6/2002A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georgia Atlanta Centers for Disease Control and Prevention Tuberculosis Trials Consortium Research Topics

Disease

1Tuberculosis (Tuberculoses)
06/2002
1Latent Tuberculosis
06/2002

Drug/Important Bio-Agent (IBA)

1rifapentine (Priftin)FDA Link
06/2002
1Isoniazid (Ftivazide)FDA LinkGeneric
06/2002
1Rifampin (Rifampicin)FDA LinkGeneric
06/2002